This is in line with one meta-analysis describing significant upregulation of ESRP1 and ESRP2 mRNA in 719 analyzed prostate cancers from 11 previous studies compared to normal prostate tissue [13]. The gene discussed is ESRP2; the disease is Familial prostate cancer.